GeneDx Holdings Corp.
NASDAQ: WGS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Katherine A. Stueland
- Employees
- 1,000
- Headquarters
- Stamford, United States
- IPO year
- 2020
- Market cap
- $1.9B
- Website
- http://www.genedx.com
Loading WGS…
Loading profile data…Frequently asked questions about WGS
What does GeneDx Holdings Corp. (WGS) do?
GeneDx Holdings Corp. functions as a health intelligence firm singularly focused on the individual patient. It aims to revolutionize healthcare delivery by deploying advanced artificial intelligence and machine learning capabilities. These sophisticated algorithms are applied to vast, longitudinal clinical and genomic datasets to construct compr...
Where does WGS trade?
GeneDx Holdings Corp. (WGS) trades on the NASDAQ Global Market.
What sector is WGS in?
GeneDx Holdings Corp. (WGS) operates in the Healthcare sector, specifically in the Medical - Healthcare Information Services industry.
Who is the CEO of GeneDx Holdings Corp.?
Katherine A. Stueland is the chief executive officer of GeneDx Holdings Corp. (WGS).
Where is GeneDx Holdings Corp. headquartered?
GeneDx Holdings Corp. is headquartered in United States.
Does WGS pay a dividend?
GeneDx Holdings Corp. (WGS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did WGS go public?
GeneDx Holdings Corp. (WGS) completed its initial public offering in 2020.